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Abstract Schisandra chinensis Turcz. (Baill.) is a
plant species whose fruits have been well known in Far
Eastern medicine for a long time. However, schisandra
seems to be a plant still underestimated in contempo-
rary therapy still in the countries of East Asia. The
article presents latest available information on the
chemical composition of this plant species. Special
attention is given to dibenzo cyclooctadiene lignans. In
addition, recent studies of the biological activity of
dibenzocyclooctadiene lignans and schisandra fruit
extracts are recapitulated. The paper gives a short
resume of their beneficial effects in biological systems
in vitro, in animals, and in humans, thus underlining
their medicinal potential. The cosmetic properties are
depicted, too. The analyticalmethods used for assaying
schisandra lignans in the scientific studies and also in
industry are also presented. Moreover, special atten-
tion is given to the information on the latest
biotechnological studies of this plant species. The
intention of this review is to contribute to a better
understanding of the huge potential of the pharmaco-
logical relevance of S. chinensis.
Keywords Schizandra ·
Dibenzocyclooctadiene lignans · Schisandrin ·
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Introduction
Schisandra chinensis (Turcz.) Baill.—Chinese mag-
nolia vine; schisandra (eng.), schizandre de Chine
(fr.), chinesische Beerentraube, chinesisches Spalt-
kölbchen (germ.), Лимoнник китaйcкий (rus.),
wuweizi, 五味子 (chin.), gomishi, ゴミシ (jap.), 오
미자, omija (kor.) is a plant species well-known in
Traditional Chinese Medicine (TCM) and also in
modern Chinese medicine. The first description of S.
chinensis species can be found in a 1596 work on
ancient Chinese medicine written by Li Shih-Chen
—“Pên T’shao Kang Mu”. The fruit of the Chinese
magnolia vine was used in the treatment of diseases of
the gastrointestinal tract, respiratory failure, cardio-
vascular diseases, in the states of body fatigue and
weakness, excessive sweating and insomnia. The
material is also known from the traditional Russian
medicine, in which it was described as a tonic,
reducing hunger, fatigue, delaying the aging process,
increasing vitality, and improving mental health
(Fil’kin 1952; Bensky and Gamble 1993).
Recent researches on the biological activity of
extracts from the fruit, as well as the main active
components isolated from this raw material—dibenzo
[a,c]cyclooctadiene lignans, have confirmed these
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properties and added new aspects relating to the
action of S. chinensis.
The most valuable, collective sources of informa-
tion on the latest research on this species are
periodically appearing review publications. The first
of the modern reviews from 1999 by Hancke et al.
(1999) signalled different aspects of the pharmacol-
ogy of S. chinensis fruit, focusing in particular on the
antihepatotoxic, antioxidant and antitumoral activi-
ties, and on the effects on physical performance and
on the central nervous system proved by scientific
researches.
A very valuable study is the publication by Opletal
et al. from 2004 (2004), in which the authors focused
on dibenzocyclooctadiene lignans. They presented
different methods of isolating these compounds and
their biological activity, paying special attention to
analytical methods. Another extensive study dealing
with the issue of the pharmacology of fruit extracts of
S. chinensis in Russian research and medicine is a
publication from 2008 written by Panossian and
Wikman (2008). This work raises the aspects of
ethnobotany and the chemical composition and
pharmacology of S. chinensis fruit. There are some
review articles in national languages, for example in
Polish, focused on different aspects of value of S.
chinensis (Ekiert 2005; Szopa et al. 2012). In recent
years there have also been reports on the biotechno-
logical research of this species. The progress
achieved in this area was presented in a monograph
by our team in the form of a book chapter by Szopa
and Ekiert (2014).
The objective of present paper is to systematize the
latest reports on the chemical composition, biological
activity and analytical testing of dibenzocyclooctadiene
lignans and S. chinensis fruit extracts. It also includes a
presentation of the position of Schisandrae chinensis
fructus in the world pharmacopoeial documents. More-
over, attention is drawn to biotechnological studies onS.
chinensis.
Botanical background and occurrence
The genus Schisandra, according to various authors,
includes from 20 to 30 species (Panossian and
Wikman 2008; World Health Organization 2007).
With the exception of one, all of the species have
their natural habitats in East and South-East Asia,
twelve of which are endemic to China (Wu et al.
2008). Only S. glabra (S. coccinea) can be found in
natural habitats in the south-eastern part of North
America (Foster 1998; Saunders 2000). The species
of Schisandra differ from one another in small details
in their morphological structure and the chemical
composition of the leaves, stems, flowers, or fruits.
Schisandra chinensis Turcz. (Baill.)—Chinese
magnolia vine, is a dioecious climbing plant. It has
its natural habitats in north-eastern China, Korea,
Japan, in the eastern part of Russia, in Primorsk, on
the Kuril Islands and in the south of the Sakhalin
Island (Bensky and Gamble 1993). The plant requires
conditions of moderate humidity and light, together
with a wet, humus-rich soil. It occurs in mixed
forests, especially on the periphery, also by streams
and brooks, usually on sandy soils (Genders 1977).
The species is grown mainly in China, Korea, Russia,
and also in North America and in many European
countries, especially for ornamental purposes.
As is specified below, the medicinal raw material
“Wuweizi (Beiwuweizi)” consists of the fruits of S.
chinensis, “Nanwuweizi” refers to the fruits of another
Schisandra species—S. sphenanthera, which is com-
mon in southern China provinces (Lu and Chen 2009;
Opletal et al. 2004). These fruits of two Schisandra
species look alike and can only be distinguished by
microscopic examination—the fruit of S. sphenanthera
has numerous oil cells and crystals in the form of prisms
or rotundish aggregates in the mesocarp. These diag-
nostic elements are not present in the fruit of S. chinensis
(Upton and Petron 1999; Upton et al. 2011). In recent
years, many analytical tests have also identified signif-
icant differences in the chemical composition of the fruit
of these two species (Lu and Chen 2009).
The fruit of S. chinensis are berries, about 1 cm in
diameter, whose exocarp and mesocarp are smooth,
shiny, of a strong red colour. The berries are clustered
in grape-like bunches about 10 cm long; in Europe,
they ripen in late August and early September. There
are 1–2 kidney-shaped seeds inside each berry (Upton
and Petron 1999; Upton et al. 2011; World Health
Organization 2007; Wu et al. 2008).
Position in worldwide pharmacopoeial documents
The medicinal raw material harvested from S.
chinensis according to traditional applications as well
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as current information in modern specification doc-
uments are the fruits. The fruits of S. chinensis have
long had their pharmacopoeial monographs in the
Chinese (2005), Japanese (2006), Korean (2002) as
well as Russian Pharmacopoeias (1990). The knowl-
edge on the fruits of S. chinensis reached the
European and American countries relatively recently.
The first monograph on Schisandrae fruit can be
found in The American Pharmacopoeia from 1999
(1999). The first official, internationally recognized,
monograph on this raw material has been available
only since 2007 in the International Pharmacopoeia
edited by WHO (2007).
In the European documents, the fruits of the
Chinese magnolia vine have been listed as a
pharmacopoeial raw material for only a few years—
since 2008. A monograph of the fruit of this species,
under the name of Schisandrae chinensis fructus
appeared for the first time in Supplement 6.3 to the
6th edition of the European Pharmacopoeia (2008). In
the latest 8th edition of the European Pharmacopoeia
(2013) valid since 2014, the monograph on Schisan-
drae chinensis fructus is still in its unchanged form.
Nevertheless, the description of the material in these
documents always distinguishes it from another, also
popular, South China species—S. sphenanthera.
Nowadays, despite its presence in the current
pharmacopoeial documents, S. chinensis is still an
interesting object in the field of medicinal chemistry
and drug discovery (Hancke et al. 1999; Opletal et al.
2004; Panossian and Wikman 2008), and has come to
the foreground of interest of phytochemical and
pharmacological research mainly due to the bioactive
dibenzocyclooctadiene lignans (Shi et al. 2014b).
Characteristic and current data on chemical
composition
Schisandra chinensis
The S. chinensis fruit is characterized by a rich, still
not fully known, chemical composition. The most
important components of the berries are dibenzo[a,
c]cyclooctadiene lignans (Table 1). Because their
occurrence is limited to this particular species, these
compounds are often referred too, even in profes-
sional publications, as “schisandra lignans” (Hancke
et al. 1999; World Health Organization 2007).
The amounts of dibenzocyclooctadiene lignans in
the fruits of S. chinensis are influenced by the degree
of fruit maturity, harvest time, the habitat and its
location. These amounts vary over a wide range, from
4 to 19 g % DW (European Pharmacopoeia 8.0 2013;
Opletal et al. 2004; World Health Organization
2007). Data from 2007, included in the WHO
monograph, referred to the presence in the fruits of
S. chinensis of thirty compounds from this group. The
earliest dibenzocyclooctadiene lignans to be identi-
fied, and found to occur in the largest quantities in the
fruits, were: schisandrin, schisandrins B and C, γ-
schisandrin, schisantherins A and B, schisanthenol,
deoxyschisandrin, gomisins A and G. These com-
pounds have a number of synonymous names that are
collected in Table 2 (Ikeya et al. 1979; Kochetkov
et al. 1961; Opletal et al. 2004; World Health
Organization 2007). The latest studies report on
newly identified structures from this group of lignans,
which have been given the name schisanchinins A–D
(Hu et al. 2014), and the first example of naturally
occurring N-containing lignan featuring a nicotinoyl
group—nicotinoylgomisin (Shi et al. 2014b). In
addition, other types of lignans have been isolated
from the fruits of S. chinensis—dibenzylbutanes
lignans: schineolignans A–C, and tetrahydrofuran
lignans: schinlignins A and B (Xue et al. 2010; Zhang
et al. 2014b) (Table 3).
Analyses of the composition of the fruits have in
recent years been focused on finding new biologi-
cally active compounds. The berries of S. chinensis
have been found to contain compounds identified as
belonging to the group of triterpenoids, such as: pre-
schisanartanes—schisanartanins A and B, and 3,4-
seco-21,26-olide-artane triterpenoid—wuweizilac-
tone acid (Huang et al. 2007; 2008; Xia et al.
2015; Xue et al. 2010). Another interesting, recently
isolated, structure is a compound from the group of
18-norschiartanes known as bisnortriterpenoids,
which do not have C-18 and C-28; it is a highly
oxygenated nortriterpenoid with unusual skeletons—
wuweizidilactone I (Xue et al. 2010) (Fig. 1).
A few years ago, the compound considered to be
the predominant colourant of S. chinensis fruit was
identified as cyanidin-3-O-xylosylrutinoside (Cya-3-
O-xylrut) (Kim et al. 2009; Ma et al. 2012a)
(Fig. 2).
The fruits of S. chinensis also contain an essential
oil in an amount of about 3 %. Sesquiterpenes are
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Table 1 The chemical parameters of selected dibenzocyclooctadiene lignans (Chiu et al. 2008; He et al. 1997; Deng et al. 2008;
Wang et al. 2011)
Lignan name Molecular
formula
Configuration Molecular
weight
(g/mol)
Fragment ions pattern Chemical structure
Deoxyschisandrin C24H32O6 R-biphenyl 416 439(M+Na)
+, 417(M+H)+, 402, 386
(M+H-CH3O)
+, 371, 370, 347(M
+H-C5H10)
+, 332, 331, 316, 315,
301, 285, 236, 182 H3CO
H3CO
H
H
CH3
CH3
H3CO
H3CO
H3CO
OCH3
Gomisin A C23H28O7 R-biphenyl 416 439(M+Na)
+, 417(M+H)+, 399(M
+H-H2O)
+, 384, 369, 368(M+H-
H2O-CH3O)
+, 357, 353, 343, 337,
323 H3CO
H3CO
H
H
CH3
CH3
H3CO
H3CO
O
O
Schisandrin C24H32O7 R-biphenyl 432 455(M+Na)
+, 433(M+H)+, 415(M
+H-H2O)
+, 400, 384(M+H-H2O-
CH3O)
+, 373, 369, 359, 353, 338,
322 H3CO
H3CO
H
H
CH3
CH3
H3CO
H3CO
H3CO
H3CO
Schisandrin B C23H28O6 R-biphenyl 400 423(M+Na)
+, 418(M+NH4)
+, 401(M
+H)+, 386, 371(M+H-CH3O)
+, 331
(M+H-C5H10)
+, 300(M+H-C5H10-
CH3O)
+, 285, 270, 258, 242, 227
H3CO
H3CO
H3CO
H3CO
CH3
CH3
H
H
O
O
Schisandrin C C23H24O6 S-biphenyl 384 407(M+Na)
+, 385(M+H)+, 354(M
+H-CH3O)
+
O
O
H3CO
H3CO
H
H
H
CH3
CH3
O
O
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dominant in the essential oil. Oxygenated monoter-
penes, monoterpenes and oxygenated sesquiterpenes
are present in smaller quantities (about 5 %). Ylan-
gene, β-himachalene, α-bergamotene and β-
chamigrene are the main components, comprising
about 75 % of the oil (Chen et al. 2011).
The most recent studies have also included anal-
yses of the composition of different groups of
polyphenols. Among the phenolic acids found in the
fruits, our team has confirmed the presence of:
chlorogenic, p-coumaric, p-hydroxybenzoic, proto-
catechuic, salicylic and syringic acids (Szopa and
Table 1 continued
Lignan name Molecular
formula
Configuration Molecular
weight
(g/mol)
Fragment ions pattern Chemical structure
γ-Schisandrin C23H28O6 R-biphenyl 400 423(M+Na)+, 418(M+NH4)+, 401(M
+H)+, 386, 371(M+H-CH3O)
+, 331
(M+H-C5H10)
+, 300(M+H-C5H10-
CH3O)
+, 285, 270, 258, 242, 227 H3CO
H3CO
H
H
CH3
CH3
O
O
H3CO
H3CO
Schisanthenol C23H30O6 R-biphenyl 402 425(M+Na)
+, 403(M+H)+, 385(M
+H-H2O)
+, 371, 370(M+H-H2O-
CH3)
+, 357, 346, 339(M+H-H2O-
CH3-CH3O)
+, 222, 182 OH
H3CO
H
H
CH3
CH3
H3CO
H3CO
H3CO
H3CO
Schisantherin A C30H32O9 S-biphenyl 536 575(M+K)
+, 559(M+Na)+, 554(M
+NH4)
+, 537(M+H)+, 415(M+H-
C-7H6O2)
+, 397(M+H-C7H6O2-
H2O)
+, 385, 373, 371(M+H-
C7H6O2-C2H4O)
+, 356, 344,
343,341, 340(M+H-C7H6O2-
C2H4O-CH3O)
+, 123, 106, 78
O
O
H3CO
H3CO
H3CO
H3CO
O
CH3
H
CH3
OH
O
Schisantherin B C28H34O9 S-biphenyl 514 537(M+Na)
+, 532(M+NH4)+, 515(M
+H)+, 415(M+H-C5H8O2)
+, 397(M
+H-C5H8O2-H2O)
+, 385, 373, 371
(M+H-C5H8O2-C2H4O)
+, 356, 344,
341, 340, 101, 84, 56
O
O
H3CO
H3CO
H3CO
H3CO
O
CH3
H
CH3
OH
O
CH3
H
CH3
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Ekiert 2012). Other authors have additionally proved
the presence of gentisic acid (Mocan et al. 2014). The
same team also confirmed the presence of compounds
from the group of flavonoids: hyperoside, iso-
quercitrin, rutin and quercetin (Mocan et al. 2014).
Moreover, S. chinensis fruits are rich in polysac-
charides and monosaccharides (glucose, fructose,
arabinose and galactose), vitamins (C and E),
phytosterols (stigmasterol, β-sitosterol), organic acids
(citric, malic, fumaric and tartaric acids) and
Table 2 The main dibenzocyclooctadiene lignans and their synonymous names
Dibenzocyclooctadiene lignans Synonymous names
Deoxyschisandrin Deoxyschizandrin, Dimethylgomisin J, Schisandrin A, Schizandrin A, Wuweizisu A
Gomisin A Schisandrol B, Schizandrol B, Wuweizisu B, Wuweizichun B, Wuweizi alcohol B
Schisandrin Schizandrin, Schisandrol A, Schizandrol A, Wuweizichun A
Schisandrin B (−)Schizandrin B, Gomisin N
Schisandrin C Schizandrin C, Wuweizisu C
γ-Schisandrin (±)γ-Schizandrin B, Wuweizisu B
Schisanthenol Schizantherol, (+)-Gomisin K3
Schisantherin A Gomisin C, Schizandrer A, Wuweizi ester A
Schisantherin B Gomisin B, Schizandrer B, Wuweizi ester B
Table 3 New confirmed lignans of S. chinensis and S. sphenanthera
S. chinensis S. sphenathera
Compound References Compound References
Dibenzocyclooctadiene lignans
Schisanchinins A–D
Nicotinoylgomisin
Shi et al. (2014b) Methylgomisin O
Chloromethyl Schisantherin B
Schisphenlignans A–E
Ren et al. (2010)
Polyoxygenated C18-dibenzocyclooctadiene lignans
nd Arisanschinins M and N
Schisphenin A
Chen et al. (2013b)
Dibenzylbutanes lignans
Schineolignans A–C Xue et al. (2010) nd
Tetrahydrofuran lignans
Schinlignins A and B Xue et al. (2010) nd
2,5-Diaryltetrahydrofuran lignans
nd Chicanine
Epigalbacine
Ganschisandrine
Liang et al. (2013)
4-Aryltetralin lignans
nd Schisandrone Liang et al. (2013)
2,3-Dimethyl-1,4-diarylbutane lignans
nd Anwulignan
Sphenanlignan
Liang et al. (2013)
nd - not detected
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bioelements (Ca, Mg, Fe, Mn, B, Zn, Cr, Ni, Cu, Co)
(Hancke et al. 1999; Szopa and Ekiert 2014; Tong
et al. 2012).
Apart from the fruits, the chemical composition of
the leaves, and often of the stems with the leaves of S.
chinensis, is also analyzed. On the basis of the
examinations of the results of analyses of the
chemical composition of the green parts of S.
chinensis, particularly noteworthy is the large number
of compounds from the group of terpenoids, espe-
cially distinctive terpenoids from cycloartane groups,
such as: schinchinenins A–H and schinchinenlactones
A–C (Fig. 3). These compounds are highly oxy-
genated triterpenoids, which is quite rare among the
constituents isolated from the Schisandra species
(Song et al. 2013). Two schinesdilactone-type nor-
triterpenoids have also been identified: schinesdi-
lactones A and B. Moreover, 16,17-seco-preschisa-
nartane nortriterpenoids: schisdilactones A–G (Wang
et al. 2012), were the first examples of these classes
isolated from the leaves and stems of S. chinensis.
Additionally, the first to be extracted from the leaves
and stems of S. chinensis were also other triter-
penoids: isoschicagenin C (Wang et al. 2012) and
schicagenins A–C (Shi et al. 2014b).
Stems with the leaves of S. chinensis are also a
source of dibenzocyclooctadiene lignans, e.g.
schisandrin, gomisins A and J, pregomisin, angeloyl-
gomisin H and Q (Zhu et al. 2015). In extracts from
the leaves, apart fromschisandrin and gomisin A,
other compounds from this group have also been
detected e.g. deoxyschisandrin,schisandrin B,
O
O
H
O
H
H
O
O
O
O
O
O
H
H
H
OH
OH
Fig. 1 Chemical structure of Wuweizidilactone I acc. to Xue
et al. (2010)
Fig. 2 The structure of predominant colourant of S. chinensis fruit—Cyanidin-3-O-xylosylrutinoside (Cya-3-O-xylrut) acc. to Kim
et al. (2009)
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gomisin G and schisantherin (Szopa and Ekiert 2011,
2013, 2015; Szopa et al. 2016a; Xiao et al. 2007), in
significant but smaller quantities than in the fruits.
Apart from the above-mentioned compounds, the
leaves have also been found to contain isoquercitrin
as the main flavonoid, followed by hyperoside, rutin,
myricetin, quercitrin, quercetin and kaempferol (Mo-
can et al. 2014); besides these, other flavonoid
glycosides occur in the leaves, such as: ((+)-isosco-
parine and quercetin 3-O-β-L-rhamnopyranosyl
(1 → 6)-β-D-glucopyranoside. Compared with the
fruits, the leaves are a richer source of phenolic
compounds, such as phenolic acids. The phenolic
acids estimated in the leaves by our team include:
chlorogenic, p-coumaric, p-hydroxybenzoic, proto-
catechuic, salicylic, syringic acids (Szopa and Ekiert
2012), and also gentisic and ferulic acids (Mocan
et al. 2014), and the precursor of one group of
phenolic acids—cinnamic acid, was determined, too
(Sovová et al. 2007).
Schisandra sphenanthera
By reviewing the research conducted in recent years,
one can observe a clear trend in the search for new
structures, especially from the group of lignans, in
other species of the genus Schisandra. Currently,
approximately 150 lignan derivatives with the diben-
zocyclooctadiene skeleton have been isolated from
plants of the Schisandraceae family, and a wide
variety of biological activities exhibited by these
lignans have been uncovered (Ren et al. 2010).
The largest number of studies is concerned with
the second, in terms of availability and prevalence in
China, species of the genus Schisandra—S. sphen-
athera. They involve determinations of the
composition of extracts not only from the fruits, but
also stems and leaves, and even roots. Analyses of the
chemical composition of the fruits of S. sphenathera
have revealed considerable differences in their com-
position in comparison with the fruits of S. chinensis.
O
H
H
OO
O
O
OAc
H
O
H
(a) Schinchinenin A
O
OR1
H
H
O
R2
OO
O
chinchinenin B (R1=Ac, R2=H)
Schinchinenin C (R1=H, R2=H)
Schinchinenin D (R1=H, R2=CO)
O
H
OR
H
O
OO
HOO
H
(b) S (c) Schinchinenin E (R1=H)
Schinchinenin F (R=Ac)
O
OR2
H
O
R1
H
O
O
H
(d) Schinchinenin G (R1=H, R2=Ac)
Schinchinenin H (R1=OH, R2=H)
O
O
O
HH
H
HH
O
(e) Schinenlactone A
O
O
H
H
H
OH
O
O
O
(f) Schinenlactone B
O
O
H
H
H
O
O
O
O
(g) Schinenlactone C
Fig. 3 Examples of recently identified triterpenoids from S. chinensis: a–d Schinchinenins A–H, e–g Schinenlactones A–C, acc.
to Song et al. (2013)
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The predominant dibenzocyclooctadiene lignans in
the fruits are: epigomisin O, 6-O-benzoylgomisin,
benzoylgomisin U methylgomisin, schisantherins A–
D, deoxyschisandrin, pre-gomisin, gomisins: C, S,
K3, J and U, myristargenol A, sphenanlignan, inte-
riotherin B, schisantherins D and E, arisantetralone A
(Chen et al. 2013b; Ren et al. 2010). In addition to
these, other lignans from this group have been
isolated and identified in the fruits of S. sphenathera
in recent years, including one polyoxygenated C18-
dibenzocyclooctadiene lignan, and also moreover one
from the group of 4-aryltetralin lignans, and two from
2,3-dimethyl-1,4-diarylbutane lignans (Chen et al.
2013b; Ren et al. 2010). On the other hand, analyses
of the composition of the stems of S. sphenanthera
have proved the existence, in addition to those
previously known, of: gomisins B, G and O,
epigomisin O, schisantherin A and D, marlignan E
and angeloylgomisin Q, and also new dibenzocy-
clooctadiene lignans—schisphenlignans A–E (Liang
et al. 2013). Moreover, the roots of S. sphenathera
have been used to isolate and identify butane-type
lignans, besides the known ones, such as: schiglau-
cins A and B, epoxyzuonin, talaumidin,
myristargenol A, and also eight previously unknown
tetrahydrofuran lignans (Jiang et al. 2015a) (Table 3).
Semisynthetic and synthetic derivatives
of schisandra lignans
The search for new structures from the group of
dibenzocyclooctadiene lignans includes not only
isolation from plant material, but also attempts to
obtain them by partial chemical synthesis. For
example, new derivatives of schisantherin A and
6,7-secoschisantherol A have been obtained by
semisynthesis. Semisynthetic schisantherin A deriva-
tives showed antiproliferative activity on four human
cancer cell lines and Id1 (an inhibitor of DNA
binding protein) and estrogenic potency (Liu et al.
2013). So far, the most successful chemical synthesis
has been the obtaining of a synthetic schisandrin C
analogue known as DDB (diphenyl dimethyl bicar-
boxylate) (Xian Nong Tan Brand®)—currently the
most potent antihepatotoxic substance, which has
been used in the treatment of chronic viral hepatitis
and chemical or drug induced hepatic damage
(Opletal et al. 2004; Wang and Xu 2008). This
compound is available in South-East Asian countries
in commonly practised therapy: in South Korea as a
drug named Hutecs (brand name—Bipheran), Dae-
woo (Lebicel), Pacific (Livital), Samjin (Peaceliva)
and UDB—biphenyl dimethyl dicarboxylate and
ursodeoxycholic acid (Pharmaking), whereas in Viet-
nam as Daewoong (Didcartuss), Bididi and Fortec
(ICA Biotechnological & Pharmaceutical) and Phar-
maKing (Nissel) in Myanmar as Hepasel (Beijing
Union).
Nevertheless, the world pharmaceutical market is
dominated by preparations (drugs and food supple-
ments) of natural origin, based on S. chinensis fruit
extract. They are quite popular in USA and East Asia
countries, but until now are less common in Europe.
Main biological modes of action
of dibenzocyclooctadiene lignans
Dibenzocyclooctadiene lignans are a large group of
chemical compounds with different modes of action.
It is, however, possible, to identify the main directions
of their biological activity (Hancke et al. 1999; World
Health Organization 2007), namely: blocking of
calcium channels (Ca2+) (Chiu et al. 2008), reducing
the level of: serum glutamic pyruvic transaminase
(SGPT), liver glutamic-pyruvic transaminase (LGPT),
alanine aminotransferase (ALT), aspartate amino-
transferase (AST), inhibition of cyclooxygenase 1
and 2 (COX 1 and 2), inhibition of the production of
nitric oxide (NO) (Blunder et al. 2010; Hu et al. 2014),
inhibition of gene expression of proinflammatory
cytokines (Oh et al. 2010), and inactivation of
cytochrome P450 (Wan et al. 2010).
In recent years, other valuable biological proper-
ties have been demonstrated for some
dibenzocyclooctadiene lignans, such as: inhibition
of platelet aggregation, the action of inhibiting the
proliferation of human immunodeficiency virus
(HIV) (Shi et al. 2014a) and adjuvant action in
cancer treatment by: inhibiting early oncogenic
activation of the Epstein-Barr virus (EBV-EA) (Chen
et al. 2002), reversing multidrug resistance dependent
on P-glycoprotein (Pgp-MDR) in tumor cells (Fong
et al. 2007), and sensitization of liver cancer cells to
the effects of doxorubicin (Hou et al. 2015; Li et al.
2006).
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Current knowledge of bioactivities
and pharmacological applications
Schisandra chinenisis fruit is known as multifunction
plant raw material. A lot of valuable applications of
these species have been proved by scientific studies
recently. Activities proved by scientific studies and
pharmacological applications were described below
and additionally were summarized in Table 4.
Hepatoprotective activity
Hepatoprotective activity is the best known profile of
action of S. chinensis fruit extracts and of individual
dibenzocyclooctadiene lignans. The available litera-
ture contains many reports on scientific studies that
confirm these properties of the fruit extracts. The
most recent ones concern detailed studies on the
mode of action of individual lignans. For example,
the mechanism of action of gomisin A has been
studied. It has been shown that it increases the
microsomal activity of: cytochrome B5, P450,
NADPH cytochrome C reductase, N-demethylase
aminophenazone, 7-ethoxycoumarin O-deethylase,
and reduces the activity of 3,4-dibenzopyrene
hydroxylase. It also accelerates the proliferation of
hepatocytes, the endoplasmic reticulum, and the
hepatic flow (Panossian and Wikman 2008; World
Health Organization 2007).
On the other hand, it has been demonstrated that
the mechanism of the hepatoprotective action of γ-
schisandrin is based on increasing the concentration
of mitochondrial glutathione. It has also been shown
that γ-schisandrin raises the concentration of vitamin
C in the liver in test animals, which may also have an
impact on its protective effect on hepatocytes and
oxidation of lipids. Moreover, schisandrin B has been
shown to protect against oxidative damage to liver
tissues, too (Thandavarayan et al. 2015).
A recently conducted study on hepatoprotective
effects of six schisandra lignans: gomisin A, schisan-
drin, deoxyschisandrin, schisandrin B, schisandrin C,
and schisantherin A, on acetaminophen-induced liver
injury has found that these effects are partially
associated with the inhibition of cytochrome-medi-
ated bioactivation. The results of morphological and
biochemical assessment of this study demonstrated
the protective effects of all the tested lignans against
acetaminophen-induced liver injury. Among the
investigated oxidative damage in liver, heart and
exerted the strongest hepatoprotective effects (Jiang
et al. 2015b).
Anti-inflammatory activity
The mechanism of anti-inflammatory action of
schisandra lignans has been elucidated. It is based
on the inhibition of the action of nitric oxide (NO)
and the production of prostaglandins by stimulating
the release of cyclooxygenase 2 (COX2) and inhibi-
tion of the expression of nitric oxide synthase (NOS)
(Hu et al. 2014).
Antioxidative and detoxification activities
Studies on the antioxidative and detoxification mech-
anisms of action of dibenzocyclooctadiene lignans
have shown that they inhibit microsomal lipid
Table 4 Main biological activities of dibenzocyclooctadiene lignans
Lignan Biological activity References
Deoxyschisandrin Anticancer, antiviral, hepatoprotective Casarin et al. (2014), Jiang et al. (2015b), Xu et al.
(2015)
Gomisin A Anticancer, antiviral, anti-inflammatory,
hepatoprotective
Jiang et al. (2015b), Waiwut et al. (2012)
Schisandrin Antioxidative, hepatoprotecitve, sedative Jeong et al. (2013)
Schisandrin B Antioxidative, anticancer, antiviral, anti-
inflammatory, hepatoprotective
Casarin et al. (2014), Chiu et al. (2006), Hu et al.
(2014), Thandavarayan et al. (2015), Xu et al.
(2015), Yim et al. (2009)
Schisandrin C Antioxidative, anti-inflammatory, hepatoprotective Jiang et al. (2015b)
γ-Schisandrin Anticancer, antioxidative, hepatoprotective Thandavarayan et al. (2015), Yim et al. (2009)
Schisanthenol Antiviral Xu et al. (2015)
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peroxidation, reduce the concentration of superoxide
radicals, inhibit microsomal NADPH oxidation in
hepatocytes and reduce the release of alanine amino-
transferase (ALT) and lactate dehydrogenase, which
increases membrane integrity and viability of hepa-
tocytes (Yim et al. 2009). Moreover, the mechanism
of protective, antioxidant and detoxifying action of
lignans on hepatocytes is based on the increase in
hepatic glutathione levels, and the activity of glu-
tathione reductase and glutathione S-transferase
(Miao et al. 2009). The latest studies have shown
that schisandrin B attenuates doxorubicin induced
cardiac dysfunction via antioxidative and anti-inflam-
matory effects. Schisandrin B has been shown to
protect against oxidative damage in liver, heart and
brain tissues in rodents (Chiu et al. 2008; Than-
davarayan et al. 2015).
Anticancer activity
Anticancer activity of schisandra lignans has been
studied in recent years. Researchers have been
identifying the compounds responsible for this activ-
ity and studying its mechanisms. They have shown
that gomisin A acts by inhibiting the production of
the placental form of glutathione S-transferase (tumor
marker) in hepatocytes and by increasing the excre-
tion of the carcinogen; it also influences cytokinesis
and reduces the number of focal neoplastic lesions in
the liver. Other studies on gomisin A have shown
anticancer activity on the colon carcinoma. It
displayed apoptotic activity through caspase-7 cleav-
age in colon carcinoma HCT-116 cells (Hwang et al.
2011). A recent investigation concerned the effects of
gomisin A on cancer cell proliferation and cell cycle
arrest in HeLa cells. Gomisin A significantly inhib-
ited cell proliferation, especially in the presence of
tumour necrosis factor-α (TNF-α) (Waiwut et al.
2012).
In vitro studies on human leukemia cells—U973, it
has been shown that another schisandra lignan—
gomisin N, induces their apoptosis. The same mech-
anism of action of gomisin N has also been confirmed
for hepatoma cells (Yim et al. 2009).
Apart from gomisin N, studies of the mechanism of
anticancer action against two human tumor cell lines
(adenocarcinoma cells—2008 and colon adenocarci-
noma cells—LoVo) also included deoxyschisandrin.
Both these lignans inhibited cell growth in a dose-
dependent manner on both cell lines, but by inducing
different types of cell death. In particular,
deoxyschisandrin caused apoptosis in colon adenocar-
cinoma cells (LoVo) but not in ovarian
adenocarcinoma cells (2008), while gomisin N
induced apoptosis on both the cell lines used (Casarin
et al. 2014).
As it turns out, the responsibility for the antitumor
activity of the extracts from the fruits of S. chinensis
is carried not only by dibenzocyclooctadiene lignans,
but also by their polysaccharide fraction. A recent
study confirmed the antitumor and immunomodula-
tory activities of water-soluble low-molecular-weight
polysaccharide from S. chinensis (Zhao et al. 2013).
Immunostimulant activity
Research conducted in recent years has focused on
studying the biological activity of the polysaccharide
fraction from extracts of the fruits of S. chinensis. The
immunostimulatory, immunomodulatory and antitu-
mor action of water-soluble low-molecular-weight
polysaccharide from S. chinensis has been proved.
The polysaccharide fraction exhibited immunomod-
ulating properties, such as improving the weight of
immune organs, enhancing the phagocytic activity of
peritoneal macrophages, promoting hemolysin for-
mation, and increasing lymphocyte transformation
(Chen et al. 2012; Zhao et al. 2013).
Influence on the central nervous system,
adaptogenic and ergogenic activities
The dibenzocyclooctadiene lignans contained in the
extract from the fruits of S. chinensis represent a
group of natural chemical structures, which are now
considered protectants against neuronal cell death
and cognitive impairment in neurological disorders.
In addition, the activity of polysaccharides contained
in the fruits of S. chinensis is also studied in this
respect. It has been shown that they, too, play an
important role by raising the level of neurotransmit-
ters in the central nervous system (Chen et al. 2012;
Zhao et al. 2013).
Extracts from the fruits of S. chinensis are used in
neurasthenia and states of exhaustion; they improve
the ability to learn and memorize, indirectly increase
alertness, improve concentration and mental perfor-
mance. They are used as adjuvant substances in the
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treatment of Alzheimer’s, Parkinson’s, and Meniere’s
diseases, and ADHD (attention deficit hyperactivity
disorder). The fruit extracts exhibit antidepressant
activity without inducing drowsiness (Jeong et al.
2013; Sa et al. 2015).
The fruits of S. chinensis have been recorded in
some East Asian pharmacopoeias as an effective
somnificant for the treatment of insomnia. However,
the mechanism of the sedative and hypnotic effects of
this plant raw material is still unclear. It has been
shown that schisandrin—the dominant compound in
S. chinensis fruit extract, produces beneficial sedative
and hypnotic bioactivity, which might be mediated by
the modification of the serotonergic system (Zhang
et al. 2014a).
Moreover, adaptogenic and ergogenic properties
of extracts from S. chinensis fruits were already well
known from the traditional use of this plant. For this
reason, S. chinensis, besides such plant species as
Eleutherococcus senticosus, Panax ginseng, Panax
quinquefolius or Rhodiola rosea, is classified as one
of the worldwide known adaptogenic raw material
(Winston and Maimes 2007).
Influence on the respiratory system
The most recent studies of the pharmacological
properties of S. chinensis fruit extracts have reported
a beneficial role in the treatment of some respiratory
system disorders.
Data from 2014 suggest that S. chinensis fruit
extracts have possible application as an antiasthmatic
drug because they lower airway hyperresponsiveness,
immunoglobuline E level, and immune cell infiltra-
tion in mice with asthma. The results also suggest that
the fruit extracts could be used as a complementary or
alternative medicine to glucocorticoids (Kim et al.
2014a).
It has also been shown that extracts from the fruits of
S. chinensis reduce cough frequency and pulmonary
inflammation in cough hypersensitivity induced in
guinea pigs by exposure to cigarette smoke. Lignans
were indicated as the compounds likely to be respon-
sible for this effect (Zhong et al. 2015).
Influence on the cardiovascular system
Recently, S. chinensis fruit extracts and the dibenzo-
cyclooctadiene lignans contained in them have gained
attention for their potential role in the treatment of
cardiovascular diseases, such as hypertension and
myocardial infarction (Alexander and Wang 2012;
Chun et al. 2014; Park et al. 2012a), which corroborates
the observed effects of this species in traditional
settings. Scientific investigations of the molecular
mechanisms behind the observed phenomena have
revealed that S. chinensis fruit extracts and its lignans
exert cardiovascular protective activity by controlling
multiple signalling pathways involved in various
biological processes, such as vascular contractility,
fibrosis, inflammation, oxidative stress, and apoptosis
(Chen et al. 2013a; Chun et al. 2014).
Anti-obesity activities
S. chinensis fruit extract has been evaluated for
inhibition effects on adipocyte differentiation in 3T3-
L1 cells and anti-obesity properties in induced obese
rats. S. chinensis fruit extracts inhibited preadipocyte
differentiation and adipogenesis in cultured cells,
leading to decreased body weight and fat tissue mass
in high-fat diet obese rats (Park et al. 2012b).
Antiviral activity
The latest research has dealt with antiviral activity of
dibenzocyclooctadiene lignans. Assays have shown
that schisandrin B and deoxyschisandrin selectively
inhibited the HIV-1 reverse transcriptase-associated
DNA polymerase activity. Schisandrin B was able to
impair the early phases of HIV-1 replication in cell-
based assays. In addition, schisandrin B was also able
to impair HIV-1 reverse transcriptase drug resistant
mutants and the early phases of viral replication.
Structure activity relationship revealed the impor-
tance of cyclooctadiene ring substituents for efficacy
(Xu et al. 2015).
Schisandra lignans are also active against plant
viruses. It has been demonstrated that the natural
product—schisanthenol and its synthetic derivatives,
were active against tobacco mosaic virus (Wang et al.
2015).
Antibacterial activity
The essential oil, and also an extract from schisandra
berry showed antibacterial effects against Gram
positive (Staphylococcus epidermidis, Staphylococcus
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aureus, Bacillus subtilis) and Gram negative (Ch-
lamydia pneumoniae, C. trachomatis, Escherichia
coli, Pseudomonas aeruginosa, Proteus vulgaris)
bacteria (Chen et al. 2011; Hakala et al. 2015).
Use in cosmetics
Due to their numerous biological properties and rich
chemical composition, extracts from S. chinensis fruit
have a beneficial effect on the condition of the skin.
Traditionally, they are attributed the following activ-
ities: toning, moisturizing, wound-healing, and
narrowing dilated blood vessels. Therefore, they have
found use in cosmetic preparations. Cosmetics con-
taining extracts of fruit of S. chinensis purify and
strengthen the protective barrier of the skin and
soothe irritations. Extracts from S. chinensis fruit
have also found use in hair care formulations. The
extracts have anti-aging and revitalizing action,
confirmed by sscientific research (Dweck and Mar-
shall 2009; Quirin 2008). In addition, studies have
shown that schisandrin B stimulates the production
of glutathione, the body’s most potent natural
antioxidant, which further confirms the validity of
the use of extracts from the fruits of S. chinensis in
anti-aging products (Chiu et al. 2011).
An extract from the fruit of S. chinensis was
approved for use for cosmetic purposes and patented
by BASF Beauty Care Solutions (Henry et al. 2012).
In 2013, the company Laboratoires Expanscience
patented, for the same purposes, an extract from the
fruit of another species—S. sphenathera (Garnier and
Msika 2013).
Structure–activity relationships of lignans
There are only a few works which describe structure–
activity relationships of lignans from S. chinensis.
Currently researches are focused on describing of
structure-anticancer activity of lignans. The presence
of a hydroxyl group at the C7 position reduced or
abolished such properties. The first effect is not
surprising since the presence of the hydroxyl group
results in an increase of the hydrophilicity, which
decrease permeability into the lipid bilayer (Gnabrea
et al. 2010). On the other hand increased activity was
observed when a methylenedioxy group was present
between C12 and C13. Anticancer action of lignans
was also connected with P-glycoprotein inhibition.
Some dibenzocyclooctadiene lignans possess three
main structural features involved in P-glycoprotein
inhibition: a 1,2,3-trimethoxy moiety, a 6-acyloxy
group, and the absence of a 7-hydroxy group (Slanina
et al. 2014). The most effective anticancer properties
based on structure–activity relationships studies were
shown for gomisin N and deoxyschisandrin (Gnabrea
et al. 2010; Slanina et al. 2014).
The next experiments elaborating structure–activ-
ity relationships of lignans were focused on their
action as platelet activating factor antagonists, where
6,7-dehydroschisandrol A showed the highest activ-
ity. Strong antiplatelet activity was shown for lignans
without an ester group at C6, a hydroxyl group at C7,
or a methylene dioxy moiety, and with an R-biphenyl
configuration (Lee et al. 1999).
About antioxidant activity of schisandra lignans
decided the exocyclic methylene group. It’s essential
for this activity. The benzoyloxy group enhancing
such effects (Choi et al. 2006).
Analytical methods in determination
of dibenzocyclooctadiene lignans
Because of described above applications of isolated
lignans and extracts from schisandra fruit in pharma-
ceuticals, food supplements and cosmetics as well as
interest in scientific research, many qualitative and
quantitative analytical methods were elaborated.
Among them the chromatographic methods prevail,
including mainly high-performance liquid chro-
matography (HPLC) and thin layer chromatography
(TLC) because of their good separation potential.
The current pharmacopoeial monographs indicate
schisandrin determination as an assay. The reference
technique used for standardization, mentioned by
European Pharmacopoeia 8th (2013), Polish Pharma-
copoeia X (2014) and WHO monograph (2007) is
HPLC. An HPLC method was utilized in determina-
tion of schisandrin and gomisin A in schisandra fruit
and leaves extracts, and in biomass extracts from
in vitro cultures (Halstead et al. 2007; Lee and Kim
2010; Zhang et al. 2009).
The second technique frequently used in analysis
of dibenzocyclooctadiene lignans in S. chinensis
preparations is TLC. European Pharmacopoeia
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monograph recommend the use of TLC method to
distinguish S. chinensis from S. sphenanthera,
because fruit of the second species has different
biosynthetic profile and is not considered as pharma-
copoeial raw material. Lignans in S. chinensis fruit
were analyzed by TLC with DART-MS (direct
analysis in real time-mass spectrometry) detection,
or with densitometric detection (Ohno et al. 2006;
Wang et al. 1991).
Other chromatographic techniques are employed
rarely. Schisandrin and gomisin A were determined
in different parts of plants (e.g. seeds, fruits, leaves
and shoots) by gas chromatography-mass spectrog-
raphy analysis (GC–MS) (Schwarzinger and
Kranawetter 2004) or in seeds by capillary elec-
trochromatography (CEC) (Kvasničková et al. 2001)
or micellar electrokinetic chromatography (MEKC)
(Tian et al. 2005). CEC and MEKC are sometimes
considered as electrophoretic techniques.
The newest methods applied to determine lignans
are: ultra-performance liquid chromatography
(UPLC) (Guo et al. 2012; Kim et al. 2014b; Sun
et al. 2013b; Yan et al. 2014; Zhou et al. 2011) and
ultra-fast liquid chromatography (UFLC) (Wei et al.
2013). Both techniques provide better possibilities
than in HPLC but obtained in different ways. UPLC
requires less time and less mobile phase. In columns
smaller particles are used and the pressure could be
very high, even up to 1200 athmospheres. These
advantages frequently result in better resolution.
UFLC is completely new technique in which instead
of high pressure the system and column performance
were improved.
Another advances in analytical procedures used in
researches of schisandra preparations concern new
techniques of extraction and purification of samples.
Among others we can mention counter current
chromatography (Chu et al. 2013; Li et al. 2014;
Zhu et al. 2014b, 2015), extraction with supercritical
CO2 (Zhu et al. 2014a) extraction with ultrasounds
(Zhang et al. 2014c), extraction with microwaves (Ma
et al. 2012b) and application of supercritical antisol-
vent precipitation (Huang et al. 2013).
Recently our team elaborated method of qualita-
tive and quantitative analysis of schisandrin and
gomisin A—HPTLC (high performance thin layer
chromatography) with densitometric detection, which
was successfully applied for determination of these
compounds in food supplements, extracts from fruits
and leaves becoming from natural source, as well
as in biomass from in vitro cultures (Ekiert et al.
2013).
Biotechnological studies
Plant in vitro cultures and possibilities of increasing
the accumulation of secondary metabolites created by
plant biotechnology are a well-known, alternative
source of many valuable biologically active sec-
ondary metabolites used in the treatment of many
diseases and also in cosmetology and food industry.
In order to obtain satisfactory, from a practical
point of view, amounts of biologically active
metabolites in in vitro plant cultures, a specific
strategy is used (Ramawat and Mathur 2007). The
elements of this strategy are, among others, the
selection of cell lines, optimization of culture condi-
tions (including selection of the basic composition of
the culture medium, selection of plant growth regu-
lators and their amounts in the media and types of
cultures—agar cultures, agitated cultures, lighting
conditions, temperature), obtaining cultures with a
high degree of organogenesis (cultures of shoots,
roots), making use of biotic or abiotic elicitors
(stressors) and genetic transformation. Increasing
the biomass production and the development of
micropropagation protocols are also important, often
key, strategies in biotechnology.
The growing interest in the medicinal values of S.
chinensis fruits in different parts of the world and the
growing number of works documenting the very
valuable biological activities of fruit extracts as well
as the individual dibenzocyclooctadiene lignans have
caused a lot of interest in this species among teams
conducting research in the field of plant biotechnol-
ogy (Szopa and Ekiert 2014).
Micropropagation protocols
Most of the biotechnological researches is dedicated
to the development of micropropagation protocols for
S. chinensis, mainly to somatic embryogenesis meth-
ods. In vitro cultures of S. chinensis have been the
object of research aimed at developing highly effec-
tive micropropagation protocols with the use of
different initial organs (zygotic embryos, cotyle-
donary leaves and hypocotyls of germinated zygotic
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embryos and female flower buds) (Smı́šková et al.
2005; Kim et al. 2005; Chen et al. 2010; Yang et al.
2011; Sun et al. 2013a) (Table 5).
Endogenic accumulation of bioactive secondary
metabolites
Apart from micropropagation studies, research has
been focused on another biotechnological aspect of
in vitro cultivation of medicinal plant species—the
endogenic accumulation of secondary metabolites in
the biomass cultured in vitro. These studies seem to
be the most important from a medicinal point of
view. Under these experiments the main attention is
focused on dibenzocyclooctadiene lignans in the
biomass of in vitro cultures of S. chinensis. The
biotechnological possibilities of producing some
schisandra lignans have been documented by teams
from the Czech Republic, Japan and Poland.
The first work of two cooperating teams from
Masaryk University, in Brno, presents the results of
only a qualitative analysis of three lignans:
deoxyschisandrin, γ-schisandrin and schisantherin A
(Havel et al. 2008).
A much broader scope of research is presented by
the second work by scientific workers from Masaryk
and Mendel Universities in Brno (Březinová et al.
2010). In their study different cell lines were
examined; three lines of embryogenic callus in agar
cultures were maintained in the dark (lines: LA-4,
LAT-52, LA-58) and five lines of suspension cultures
were maintained in a photoperiod (lines: LA-1, LA-4,
LA-10, LAT-52, LA-58). All of the cell lines were
grown on Westvaco medium-WV5 (Lloyd and
McCown 1980), with 2 % sucrose, 2 mM glutamine
and plant growth regulators (PGRs): 6-benzy-
laminopurine (BA) and 2,4-dichlorophenoxyacetic
acid (2,4-D). In the embrogenic callus solid cultures
there were six lignans present: schisandrin, gomisin
A, deoxyschisandrin, γ-schisandrin, gomisin N and
schisandrin C. In the suspension cultures of the five
cell lines, the presence of all six compounds tested for
was also revealed, although some of them were
present only in trace amounts. As a result of the
selection of the cell lines, only some of the
compounds could be obtained in amounts that might
be of interest from a practical point of view: in
embriogenic callus solid cultures—gomisin N
(54.7 mg/100 g DW (dry weight)), in suspension
cultures—γ-schisandrin (55.0 mg/100 g DW), gomi-
sin N (26.7 mg/100 g DW) and schisandrin C
(20.9 mg/100 g DW) (Table 6). The most effective
cell line in solid callus cultures was LAT-52, in
suspension cultures LAT-52 and LA-1. The main
compounds in the plant organs analyzed for compar-
ative purposes were different lignans—in the seeds:
schisandrin and deoxyschisandrin, while in the
leaves: gomisin A and schisandrin.
Another work, which is a result of cooperation of
three research units from Hiroshima University and
Graduate School of Biomedical Sciences from
Hiroshima, presents the possibility of producing two
of the six lignans analyzed—gomisin A and gomisin
F, in the established callus cultures. Callus cultures
were maintained on Murashige and Skoog (MS)
(1962) and Woody Plant (WP) (Lloyd and McCown
1980) media in full and half strength (1/2 MS or 1/2
WP) salt formulations, additionally following PGRs
Table 5 Studies on micropropagation protocols of S. chinensis via somatic embryogenesis
Explant Media PGRs References
Zygotic embryos from seeds MS; Westvaco 2,4-D; BA; IBA;
TDZ
Smı́šková et al.
(2005)
Zygotic embryos from seeds MS; Merkle and
Somer
2,4-D; BA; Zt Kim et al. (2005)
Cotyledonary leaves and hypocotyls of germinated zygotic
embryos
MS BA; GA3 Chen et al. (2010)
Female flower buds MS 2,4-D; GA3 Yang et al. (2011)
Zygotic embryos from seeds MS 2,4-D; TDZ; Zt Sun et al. (2013a)
PGRs - plant growth regulators, 2,4-D - 2,4-dichlorophenoxyacetic acid, BA - 6-benzylaminopurine, GA3 - gibberellic acid,
IBA - 3-indolebutyric acid, NAA - 1-naphthaleneacetic acid, TDZ - thidiazuron, Zt - zeatin
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Table 6 Maximal contents (mg/100 g DW) of dibenzocyclooctadiene lignans obtained by different research teams under
biotechnological studies on in vitro cultures of S. chinensis
Lignans Maximal
content
Type of in vitro culture Medium and
PGRs
References
Angeoyl-/Tigloylgomisin
H
26.66 Shoot-differentiating callus agar
culture
MS
BA—3 mg/l
NAA—1 mg/l
Szopa et al. (2016a)
Angeoyl-/Tigloylgomisin
Q
51.24 Shoot-differentiating callus culture MS
BA—3 mg/l
NAA—1 mg/l
Szopa et al. (2016a)
Benzoylgomisin P 18.74 Stationary liquid shoot culture MS
BA—3 mg/l
NAA—1 mg/l
Szopa et al. (2016a)
Deoxyschisandrin 308.51 Shoot-differentiating callus culture MS
BAP—3 mg/l
NAA—1 mg/l
Szopa and Ekiert (2013)
Gomisin A 86.41 Shoot-differentiating callus culture MS
BAP—3 mg/l
NAA—1 mg/l
Szopa and Ekiert (2011)
Gomisin F 40.00 Callus solid culture ½ MS
KIN—0.05 mg/l
2,4-D—0.2 mg/l
Kohda et al. (2012)
Gomisin G 1.91 Shoot agitated culture MS
BA—3 mg/l
NAA—1 mg/l
Szopa et al. (2016a)
Gomisin N 54.70 Embriogenic callus
(cell line: LAT-52)
Westvaco
BAP—0.9 mg/l
2,4-D—2.21 mg/l
Brezinová et al. (2010)
Schisandrin 70.54 Shoot-differentiating callus culture MS
BAP—3 mg/l
NAA—1 mg/l
Szopa and Ekiert (2011)
Schisandrin B 20.70 Shoot agitated culture MS
BA—3 mg/l
NAA—1 mg/l
Szopa et al. (2016a)
Schisandrin C 20.90 Suspension culture
(cell line: LA-1)
Westvaco
BAP—0.9 mg/l
2,4-D—2.21 mg/l
Brezinová et al. (2010)
γ-Schisandrin 55.00 Suspension culture
(cell line: LA-1)
Westvaco
BAP—0.9 mg/l
2,4-D—2.21 mg/l
Brezinová et al. (2010)
Schisanthenol 1.28 Shoot agitated culture MS
BA—3 mg/l
NAA—1 mg/l
Szopa et al. (2016a)
Schisantherin A 2.97 Shoot agitated culture MS
BA—3 mg/l
NAA—1 mg/l
Szopa et al. (2016a)
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were tested: 2,4-D, BA, 3-indolebutyric acid (IBA)
and kinetin (KIN). All biomass extracts contained
only two dibenzocyclooctadiene lignans: gomisin A
and F. Under the chosen optimal conditions, gomisin
A and gomisin F contents were 0.05 and 0.04 g %
DW, respectively. Interestingly, they were higher
than in the plant organs (leaves and fruits) analyzed
for comparative purposes (Kohda et al. 2012)
(Table 6).
Our team from the Jagiellonian University,
Kraków, has been conducting studies on in vitro
cultures of S. chinensis since 2010. These studies
seem to be the most advanced in relation to the
accumulation of dibenzocyclooctadiene lignans.
Established in vitro cultures were used to perform
studies concerning the accumulation of dibenzocy-
clooctadiene lignans in the biomass of S. chinensis
in vitro cultures at different stages of morphogenesis:
shoot-differentiated callus and undifferentiated callus
cultures, and also in different forms: an agar,
stationary liquid and agitated cultures. Cultures were
tested in different conditions; different media: MS
and Linsmaier and Skoog (LS) (1965), and various
concentrations of PGRs: BA and 1-naphthaleneacetic
acid (NAA), were tested. Apart from schisandra
lignans, qualification and quantification of phenolic
acids were also performed. Under the research,
almost all of the biotechnological steps of the
cultivation of plants in vitro cultures were completed.
At the beginning, after the initiation of cultures,
the impact of different plant growth regulators: BA
and NAA, on the accumulation of schisandra lignans
was studied. Extracts from the biomass of shoot-
differentiating and undifferentiating callus cultures of
S. chinensis growing on variants of the MS medium,
with different concentrations of BA and NAA were
analyzed for the accumulation of six lignans:
schisandrin (max. 70.54 mg/100 g DW) and gomisin
A (max. 86.41 mg/100 g DW) (Szopa and Ekiert
2011), deoxyschisandrin (max. 308.51 mg/100 g
DW) and γ-schisandrin (max. 22.09 mg/100 g DW)
(Szopa and Ekiert 2013) and gomisin G (max.
21.89 mg/100 g DW) and schisantherin A (max.
33.45 mg/100 g DW) (Szopa and Ekiert 2015)
(Table 6). The amounts of these compounds in the
biomass extracts were dependent on the concentration
of plant growth regulators in the MS medium. The
amounts of the tested compounds found in the
extracts from the undifferentiated callus cultures
were considerably smaller than in the extracts from
cultures with a higher degree of differentiation. In
addition, the identity of the three lignans estimated
(deoxyschisandrin, gomisin A and schisandrin), after
isolation and purification by chromatographic meth-
ods from the biomass cultured in vitro, was also
confirmed by spectral analysis (1H-NMR) (Szopa
et al. 2015).
Under the latest studies, performed 3 years after
the previous experiments, in cooperation with a teams
from Medical University of Gdańsk and Nicolaus
Copernicus University of Toruń shoot-differentiating
callus cultures of S. chinensis were cultured in
different in vitro systems—in an agar system and
also in two different liquid systems: stationary and
agitated. Quantification of fourteen dibenzocyclooc-
tadiene lignans (angeoyl-/tigloylgomisins H and Q,
benzoylgomisin P, deoxyschisandrin, gomisins A and
G, schisandrin, schisandrins B and C, γ-schisandrin,
schisanthenol, schisantherins A, B and D) was
performed in the extracts from the biomass and from
the media. Some of them (angeoyl-/tigloylgomisins H
and Q, benzoylgomisin P, schisantherins D), were
tentatively identified. The main lignans detected in
the biomass extracts from all the tested systems were:
Table 6 continued
Lignans Maximal
content
Type of in vitro culture Medium and
PGRs
References
Schisantherin B 5.70 Shoot agitated culture MS
BA—3 mg/l
NAA—1 mg/l
Szopa et al. (2016a)
Schisantherin D 5.65 Stationary liquid shoot culture MS
BA—3 mg/l
NAA—1 mg/l
Szopa et al. (2016a)
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schisandrin (max. 65.62 mg/100 g DW), angeloyl-/
tigloylgomisin Q (max. 49.73 mg/100 g DW),
deoxyschisandrin (max. 43.65 mg/100 g DW) and
gomisin A (max. 34.36 mg/100 g DW) (Table 6). The
lignans were not detected in the media. The amount
of the main schisandra lignan—schisandrin, was 2.21
times higher in biomass extracts than in the extracts
from the leaves of the parent plant, analyzed for
comparison, but 2.02 times lower than in the fruits.
Also, the maximum amounts of the other main
lignans: gomisin A and deoxyschisandrin, were
comparable with their amounts in the leaves, but
3.18 and 1.39 times lower than in the fruits,
respectively (Szopa et al. 2016a).
High amounts of lignans are also determined by
the high degree of organogenesis of the biomass
studied. These results suggest that the in vitro culture
of S. chinensis can be a potential alternative source of
lignans. The other significant outcome of the studies
performed so far is the finding that the investigated
biomass is suitable for cultivation in liquid systems;
therefore, S. chinensis in vitro cultures are a good
model for further studies on the accumulation of
lignans, particularly in large-scale installations
(bioreactors). These studies are in progress. Experi-
ments are being performed on the basis of large-scale
bioreactors such as: a bubble column with shoot
immobilization system, balloon-type bubble and
spray bioreactors, and also some commercially
available constructions.
A comparative list of the maximum amounts of
dibenzocyclooctadiene lignans obtained by different
research teams under biotechnological studies in
various types of in vitro cultures of S. chinensis is
shown in Table 6.
A study focused on the analysis of phenolic acids
in the biomass of in vitro cultures of S. chinensis was
also performed by our team (Szopa and Ekiert 2012).
The amounts of free phenolic acids and cinnamic acid
were determined using the HPLC method in extracts
from the biomass of S. chinensis at different stages of
organogenesis (shoot-differentiating and undifferen-
tiating callus cultures), cultured in vitro on several
variants of the MS medium, containing different
concentrations of PGRs, and in extracts from over-
ground parts of plants growing in vivo. The acids
detected in the extracts from in vitro cultured biomass
included: chlorogenic, p-coumaric, p-hydroxyben-
zoic, protocatechuic, salicylic and syringic acids.
The maximum total amounts of the metabolites
estimated in the biomass of shoot-differentiating
callus culture was equal to 60.05 mg/100 g DW.
Interestingly, the maximum total content in biomass
extracts from undifferentiating callus culture, with a
lower degree of differentiation, was higher and
amounted to 78.24 mg/100 g DW. The maximum
total amounts of phenolic acids in both types of
in vitro cultures were greater than in the fruits and
leaves of plants growing in vivo. The studies on the
accumulation of phenolic acids in the biomass
cultivated in different bioreactors are also in progress.
Biotransformation reactions
A quite interesting aspect of the biotechnological
studies that were performed on in vitro cultures of S.
chinensis was the testing of the biotransformation
capability of the cells cultured in vitro. These studies
use the enzymatic potential of plant cells cultured
in vitro for the biotransformation of exogenously
supplied simple substrates to expected products. The
most notable reaction is O-β-D-glucosylation of
hydroquinone into arbutin, an important product in
therapy and cosmetology. The possibility of using
microorganisms in these processes is limited because
the reaction of O-α-D-glucosylation proceeds in
microorganisms better than O-β-D-glucosylation
(Fig. 4).
Preliminary studies on biotransformations were
performed by a team from Charles University in
Prague. The researchers studied the biotransformation
capacity of various exogenous precursors of arbutin
and salicin (phenylalanine, salicylic aldehyde, hydro-
quinone, cinnamic acid, o-coumaric acid, p-coumaric
acid, p-anisoic acid, helicin and salicylic acid) in
in vitro cultures of four plant species, including S.
chinensis callus cultures. In S. chinensis in vitro
cultures there occurred β-D-glucosylation of hydro-
quinone into arbutin. The maximum amount of the
product, equal to 5.08 g %, was obtained 7 days after
administering the precursor at a dose of 100 ml per
litre of medium (Dušková et al. 1999; Dušková et al.
2005).
In the latest research, an experiment on the enzy-
matic potential of cells from in vitro culture of S.
chinensis in biotransformation processes was also
undertaken by our team from Jagiellonian University,
Kraków. Under this study, optimization of the process
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of biotransformation of hydroquinone into arbutin was
performed in agitated shoot cultures of this plant
species. The optimization involved testing various
concentrations of the precursor (100–400 mg/l of
medium) and different ways of administering it (single
dose, or divided into two or three portions). Arbutin
was accumulated mainly in the in vitro cultured
biomass (85.2–98.6 %); the highest amount
(39.02 mg/g DW) was found after administering of
384 mg/l hydroquinone in a dose divided into two
portions. A preliminary experiment with the biotrans-
formation of 4-hydroxybenzoic acid as a precursor did
not produce any arbutin but a mixture of two other
compounds, products of glucosylation of the precursor
—4-hydroxybenzoic acid 4-O-β-glucopyranoside and
4-hydroxybenzoic acidβ-glucopyranosyl ester (Fig. 5).
The identity of all the biotransformation products was
confirmed by 1H-NMR analysis. These results addi-
tionally indicate a widespread possibility of the
enzymatic glycosylation reactions in in vitro plant
cultures (Szopa et al. 2016b).
Conclusions
Presented review proved, that S. chinensis is very
plausible object of the different scientific studies.
Chemical analyses have been concerned with the
isolation and identification of new structures of sec-
ondarymetabolites occurring in the fruits and also in the
leaves and stems of S. chinensis, and in other Schisandra
species. The current pharmacological researches con-
firm the already known activities of S. chinensis and
report on new potential health-promoting activities of
this species and its usefulness also in cosmetology. The
studies have been focused on fruit extracts and also on
the activities of individual dibenzocyclooctadiene lig-
nans. The developed analytical methods, which are the
best tool for qualification and quantification assays of
schisandra lignans, are also becoming increasingly
more precise, also important are elaborated new tech-
niques of extraction and purification of samples.
Moreover, the phytochemical studies are being
expanded and enriched with biotechnological studies.
The biotechnological methods of producing dibenzo-
cyclooctadiene lignans (especially micropropagarion
and endogenic accumulation) that are so valuable froma
pharmacological point of view seem to provide a very
promising alternative way of obtaining these metabo-
lites in the future.
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Sovová H, Opletal L, Bártlová M et al (2007) Supercritical
fluid extraction of lignans and cinnamic acid from
Schisandra chinensis. J Supercrit Fluid 42:88–95
State Pharmacopoeia of the Russian Union of Soviet Socialist
Republic (1990) Pharmacopoeia Committee, Ministry of
Health, Moscow
Sun D, Lang WX, Li HB et al (2013a) An improve method for
somatic embryogenesis of Schisandra chinensis (Turcz.)
Baillon. Pak J Biol Sci 16:127–134
Sun H, Wu F, Zhang A et al (2013b) Profiling and identifica-
tion of the absorbed constituents and metabolites of
schisandra lignans by ultra-performance liquid chro-
matography coupled to mass spectrometry. Biomed
Chromatogr 27:1511–1519
Szopa A, Ekiert H (2011) Lignans in Schisandra chinensis
in vitro cultures. Pharmazie 66:633–634
Szopa A, Ekiert H (2012) In vitro cultures of Schisandra chi-
nensis (Turcz.) Baill. (Chinese magnolia vine)—a
potential biotechnological rich source of therapeutically
important phenolic acids. Appl Biochem Biotechnol
166:1941–1948
SzopaA, Ekiert H (2013) Production of deoxyschizandrin andγ-
schizandrin in shoot-differentiating and undifferentiating
callus cultures of Schisandra chinensis (Turcz.) Baill.
(Chinese magnolia vine). J Biotechnol 165:209–213
Szopa A, Ekiert H (2014) Schisandra chinensis (Turcz.) Baill.
(Chinese magnolia vine) in vitro cultures. In: Govil JN
(ed) Recent progress in medicinal plants. Biotechnology
and genetic engineering II, vol 39. Studium Press LLC,
Houston, pp 405–434
Szopa A, Ekiert H (2015) Production of schisantherin A and
gomisin G in in vitro cultures of Schisanda chinensis.
Phytochem Let 11:440–444
Szopa A, Ekiert R, Ekiert H (2012) Cytryniec chiński
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